
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Switch from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/switch/topic/6998/</link>
        <description>Articles tagged with Switch from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>After rough &apos;12, PHCG looks to inject more life into business</title>
          <description>An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.</description>
          <link>http://www.mmm-online.com/after-rough-12-phcg-looks-to-inject-more-life-into-business/article/290582/</link>
          <pubDate>Thu, 25 Apr 2013 18:50:41 GMT</pubDate>
          <itunes:summary>An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Study: OTC ads are so over risk info</title>
          <description>A study of advertising for OTC switches found that presentation of risk information plummeted once the products advertised escaped the purview of the FDA.</description>
          <link>http://www.mmm-online.com/study-otc-ads-are-so-over-risk-info/article/258712/</link>
          <pubDate>Wed, 12 Sep 2012 18:01:10 GMT</pubDate>
          <itunes:summary>A study of advertising for OTC switches found that presentation of risk information plummeted once the products advertised escaped the purview of the FDA.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pfizer bets on Rx-to-OTC Nexium switch</title>
          <description>The drugmaker is paying $250 million to Nexium marketer AstraZeneca for the rights to sell an OTC version, in a deal that may signal a deepening relationship between the two firms.</description>
          <link>http://www.mmm-online.com/pfizer-bets-on-rx-to-otc-nexium-switch/article/254584/</link>
          <pubDate>Tue, 14 Aug 2012 17:07:56 GMT</pubDate>
          <itunes:summary>The drugmaker is paying $250 million to Nexium marketer AstraZeneca for the rights to sell an OTC version, in a deal that may signal a deepening relationship between the two firms.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>OTC Lipitor? Good luck with that</title>
          <description>Pfizer is reportedly weighing an attempt at an over-the-counter (OTC) switch for Lipitor - a move that could help the company recoup some of its losses when the $11 billion drug loses US exclusivity in November -- but the reception from analysts has been muted so far.</description>
          <link>http://www.mmm-online.com/otc-lipitor-good-luck-with-that/article/209085/</link>
          <pubDate>Thu, 04 Aug 2011 20:13:12 GMT</pubDate>
          <itunes:summary>Pfizer is reportedly weighing an attempt at an over-the-counter (OTC) switch for Lipitor - a move that could help the company recoup some of its losses when the $11 billion drug loses US exclusivity in November -- but the reception from analysts has been muted so far.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Prevacid OTC switch gets $200 million launch effort</title>
          <description>Novartis Consumer Health launched OTC Prevacid with a $200 million marketing campaign featuring the tagline: &quot;When you&apos;ve had it with heartburn.&quot;</description>
          <link>http://www.mmm-online.com/prevacid-otc-switch-gets-200-million-launch-effort/article/158035/</link>
          <pubDate>Wed, 18 Nov 2009 20:00:57 GMT</pubDate>
          <itunes:summary>Novartis Consumer Health launched OTC Prevacid with a $200 million marketing campaign featuring the tagline: &quot;When you&apos;ve had it with heartburn.&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  